Clinical Trials Browser

Adenocarcinoma, Clear Cell × Celecoxib × Clear all

NCT00231829 2012-04-24

A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers

Phase 2 Terminated

Uterine Neoplasms, Adenocarcinoma, Clear Cell